Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?
Background: The National Lung Screening Trial demonstrated that screening for lung cancer improved overall survival (OS) and reduced lung cancer mortality in the 55-74-year-old age group by increasing the proportion of cancers detected at an early stage. Because of the increasing life expectancy of...
Main Authors: | John eVarlotto, Malcolm M. DeCamp, John eFlickinger, Jessica eLake, Abram eRecht, Chandra eBelani, Michael eReed, Jennifer eToth, Heath eMackley, Christopher eSciamanna, Alan eLipton, Suhail eAli, Richkesvar eMahraj, Christopher eGilbert, Nengliang eYao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00037/full |
Similar Items
-
The reverse transcriptase encoded by LINE-1 retrotransposons in the genesis, progression and therapy of cancer
by: Ilaria eSciamanna, et al.
Published: (2016-02-01) -
Characterization of the rainbow trout spleen transcriptome and identification of immune-related genes
by: Ali eAli, et al.
Published: (2014-10-01) -
Immunostimulation by synthetic lipopeptide based vaccine candidates: structure-activity relationships.
by: Mehfuz eZaman, et al.
Published: (2013-10-01) -
Lipid- and sugar-modified endomorphins: Novel targets for the treatment of neuropathic pain
by: Pegah eVaramini, et al.
Published: (2013-12-01) -
The vulnerability of calretinin-containing hippocampal interneurons in temporal lobe epilepsy
by: Zsofia eMagloczky, et al.
Published: (2014-09-01)